Abortion Pill Rulings

Drug Company Leaders Condemn Ruling Invalidating F.D.A.’s Approval of Abortion Pill

More than 400 executives said that the decision ignored both scientific and legal precedent and that, if the ruling stood, it would create uncertainty for the pharmaceutical and biotech industries.

By Pam Belluck and Christina Jewett

April 10, 2023

The pharmaceutical industry plunged into a legal showdown over the abortion pill mifepristone on Monday, issuing a scorching condemnation of a ruling by a federal judge that invalidated the Food and Drug Administration’s approval of the drug and calling for the decision to be reversed.

https://acrobat.adobe.com/link/review?uri=urn:aaid:scds:US:a43b12dc-1579-3cfb-8e68-db4f145e2477

The statement was signed by more than 400 leaders of some of the drug and biotech industry’s most prominent investment firms and companies, none of which make mifepristone, the first pill in the two-drug medication abortion regimen. It shows that the...

https://www.nytimes.com/2023/04/10/health/abortion-ruling-pharma-executives.html?smid=url-share

Read PDF version here:

https://acrobat.adobe.com/link/review?uri=urn:aaid:scds:US:8e8094bb-464c-3f69-8848-9acb250fdc57